| Chad Sharp, MD | |
|
301 N Main St, Suite 300, Newton, KS 67114-3444 | |
| (316) 282-9614 | |
| (316) 284-9602 |
| Full Name | Chad Sharp |
|---|---|
| Gender | Male |
| Speciality | Family Medicine |
| Location | 301 N Main St, Newton, Kansas |
| Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1194853531 | NPI | - | NPPES |
| 04-24831 | Other | KS | LICENSE |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207Q00000X | Family Medicine | 04-24831 (Kansas) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Chad Sharp, MD Po Box 245, 1006 Chestnut, Ashland, KS 67831-0245 Ph: (316) 258-5019 | Chad Sharp, MD 301 N Main St, Suite 300, Newton, KS 67114-3444 Ph: (316) 282-9614 |
News Archive
An innovative new Consortium will act as a ‘match-making' service between pharmaceutical companies and researchers in Cambridge with the aim of developing and studying precision medicines for some of the most globally devastating diseases.
The Cardiovascular Research Foundation (CRF) of New York, NY and the Uppsala Clinical Research Center (UCR) of Uppsala, Sweden announced today the initiation of the PROSPECT (Providing Regional Observations to Study Predictors of Events in the Coronary Tree) II trial and the PROSPECT ABSORB sub study.
SCIENTISTS at the University of Huddersfield are the first to arrive at a deep understanding of a molecule that destroys cancerous tumours without harming healthy cell tissue.
Today, at the 2013 World Molecular Imaging Congress (WMIC), Bruker introduces a new multimodal animal bed enabling multiple sequential imaging sessions in preclinical research with robust repositioning between scans, while avoiding unwanted motion of the animal during the investigation. This optimizes results for image fusion, combined processing and evaluation of preclinical research applications requiring multiple imaging modalities across multiple systems.
Anacor Pharmaceuticals announced today that it has completed enrollment in the first of two Phase 3 trials of tavaborole (formerly known as AN2690), a topical anti-fungal product candidate for the treatment of onychomycosis.
› Verified 4 days ago
Michael K Williams, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 720 Medical Center Dr, Newton, KS 67114 Phone: 316-283-6103 Fax: 316-283-1333 | |
Richard M Glover Ii, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 700 Medical Center Dr, Ste 210, Newton, KS 67114 Phone: 316-283-2800 Fax: 316-283-3575 | |
Timothy B Wiens, MD Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 720 Medical Center Dr, Newton, KS 67114 Phone: 316-283-6103 Fax: 316-283-1333 | |
Leslie M Luinstra, MD Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 720 Medical Center Dr, Newton, KS 67114 Phone: 316-284-5155 Fax: 316-284-5110 | |
Angel Teck, DO Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 720 Medical Center Dr, Newton, KS 67114 Phone: 131-628-3610 Fax: 316-284-5050 | |
Jana Nisly, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 720 Medical Center Dr, Newton, KS 67114 Phone: 316-283-6103 | |
Troy Allen Holdeman, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 700 Medical Center Dr, Suite 210, Newton, KS 67114 Phone: 316-283-2800 |